If you have diabetes, taking steps to manage it can help prevent related health issues, including MASH. Here’s what to know to protect your liver.

Sanofi SNY and Roche RHHBY announced their fourth-quarter and full-year 2024 results. Novo Nordisk’s NVO novel obesity ...

People with Type 1 or Type 2 diabetes make up over a quarter of those waiting for an organ transplant in Wisconsin. People ...

The study offers promising news for people with type 2 diabetes. By using SGLT2 inhibitors, they may be able to lower their ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

Adults with diabetes, heart disease, heart failure, hypertension, or kidney failure may ignore dietary restrictions due to exposure to foods advertised during sporting events.

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Advances in medical treatment for cardiovascular disease, a leading cause of death in the U.S., have helped patients live longer. But a new report finds that risk factors that lead to heart disease ...

The FDA approved Ozempic to treat kidney disease in Type 2 diabetes patients after trials showed it reduces the risk of ...